A site-resolved post-translational modification framework for drug-response analysis

Post-translational modifications (PTMs) regulate protein activity and treatment-associated signalling, providing functional information that can connect drug-response estimates with candidate pharmacodynamic measurements. Assessing this information requires a framework that determines its contribution beyond fixed molecular features while retaining the identity of the modified sites underlying model predictions. We developed the PTM Biological Dynamics Layer (PTM-BDL), which integrates typed PTM states with protein sequence, structure-derived and drug chemical features to predict log-transformed half-maximal inhibitory concentration and resistance while providing site-level interpretation through integrated gradients. Retrospective evaluation used source-derived and propagated PTM profiles across biologically distinct BCR-ABL, HDAC/EP300 and EGFR/ERBB2 settings, yielding internal areas under the receiver operating characteristic curve (AUROCs) between 0.785 and 0.946. Retraining demonstrated a consistent incremental contribution from PTM inputs in K562/CML, with a mean AUROC increase of 0.0268 and positive gains in all five folds, alongside more modest incremental gains in HeLa/HDAC and EGFR/ERBB2. Within K562/CML, CRKL Y207 and STAT5A Y694 retained the leading attribution ranks for their proteins across three seeds, while greater PTM attribution in dasatinib than in cytotoxic drug contexts identified a focused setting for pharmacodynamic investigation. These findings support context-dependent use of PTM information and connect predictive assessment with prioritisation of individual sites, providing a basis for targeted pharmacodynamic measurements and independent experimental validation.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.19.767872
Primary Topic
Computational Drug Discovery Methods
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A site-resolved post-translational modification framework for drug-response analysis

Moustafa Zein, Aboul Ella Hassanien
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Computational Drug Discovery Methods
preprint

A site-resolved post-translational modification framework for drug-response analysis

Moustafa Zein, Aboul Ella Hassanien
preprint en

Abstract

Post-translational modifications (PTMs) regulate protein activity and treatment-associated signalling, providing functional information that can connect drug-response estimates with candidate pharmacodynamic measurements. Assessing this information requires a framework that determines its contribution beyond fixed molecular features while retaining the identity of the modified sites underlying model predictions. We developed the PTM Biological Dynamics Layer (PTM-BDL), which integrates typed PTM states with protein sequence, structure-derived and drug chemical features to predict log-transformed half-maximal inhibitory concentration and resistance while providing site-level interpretation through integrated gradients. Retrospective evaluation used source-derived and propagated PTM profiles across biologically distinct BCR-ABL, HDAC/EP300 and EGFR/ERBB2 settings, yielding internal areas under the receiver operating characteristic curve (AUROCs) between 0.785 and 0.946. Retraining demonstrated a consistent incremental contribution from PTM inputs in K562/CML, with a mean AUROC increase of 0.0268 and positive gains in all five folds, alongside more modest incremental gains in HeLa/HDAC and EGFR/ERBB2. Within K562/CML, CRKL Y207 and STAT5A Y694 retained the leading attribution ranks for their proteins across three seeds, while greater PTM attribution in dasatinib than in cytotoxic drug contexts identified a focused setting for pharmacodynamic investigation. These findings support context-dependent use of PTM information and connect predictive assessment with prioritisation of individual sites, providing a basis for targeted pharmacodynamic measurements and independent experimental validation.

bioRxiv (Cold Spring Harbor Laboratory)
Cairo University (EG)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
A site-resolved post-translational modification framework for drug-response analysis — Moustafa Zein, Aboul Ella Hassanien · bioRxiv (Cold Spring Harbor Laboratory) (2026) | TGRS Research Map | TGRS